Jacqueline Elizabeth Shea Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Jacqueline Elizabeth Shea is Chief Executive Officer of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 33,647 shares of INO, which is worth approximately $64,938. The most recent transaction as insider was on Feb 01, 2021, when has been sold 28,336 shares (Common Stock) at a price of $15.03 per share, resulting in proceeds of $425,890. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.6K

0% 3M change

83.02% 12M change

Total Value Held $64,938

Jacqueline Elizabeth Shea Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2021	SELL Open market or private sale	$425,890 $15.03 p/Share	28,336 Reduced 42.37%	38,535 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$81,001 $3.62 p/Share	22,376 Added 25.07%	66,871 Common Stock
Jan 28 2021	SELL Open market or private sale	$201,225 $12.04 p/Share	16,713 Reduced 27.31%	44,495 Common Stock
Jan 28 2021	BUY Exercise of conversion of derivative security	$199,998 $3.62 p/Share	55,248 Added 47.44%	61,208 Common Stock
Jan 27 2021	SELL Open market or private sale	$340,882 $12.03 p/Share	28,336 Reduced 82.62%	5,960 Common Stock
Jan 27 2021	BUY Exercise of conversion of derivative security	$81,001 $3.62 p/Share	22,376 Added 39.48%	34,296 Common Stock

JES

Jacqueline Elizabeth Shea

Chief Executive Officer

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account